ğŸ“Œ Project Overview

This project focuses on risk stratification by predicting the probability of death for patients using clinical and demographic data. 
The model outputs a continuous death probability rate, enabling nuanced risk assessment rather than a binary outcome. This approach supports early identification of high-risk patients and better-informed decision-making.

ğŸ“Š Dataset Description
The dataset contains patient-level clinical information, including demographic attributes, cancer-related variables, and outcome indicators. The death probability rate is used as the target variable, while the binary death label is excluded to prevent data leakage.

âš™ï¸ Data Preprocessing
The data undergoes multiple preprocessing steps to ensure high-quality model input:
Featureâ€“target separation with death probability rate as the prediction target
Encoding of categorical variables such as gender and cancer type
Standardization of time-based features such as years since diagnosis
These steps ensure consistent feature scaling and improve model stability.

ğŸ”€ Model Training and Validation
The dataset is split into training and testing sets using an 80â€“20 ratio. A Random Forest regression model is employed to learn complex, non-linear relationships between patient features and mortality risk.
Model performance is optimized using randomized hyperparameter tuning with cross-validation, balancing accuracy and computational efficiency.

ğŸ“ˆ Model Output and Evaluation
The model produces a predicted death probability rate for each patient, expressed as a continuous value. Performance is evaluated on unseen data using:
Mean Absolute Error (MAE)
Mean Squared Error (MSE)
Root Mean Squared Error (RMSE)
These metrics assess how closely the predicted probability rates align with actual outcomes.

ğŸ” Model Explainability
To ensure transparency, SHAP-based explainability is applied:
Global feature importance identifies key risk contributors
Feature impact analysis explains how individual patient attributes increase or decrease the predicted death probability rate
This makes the model suitable for high-stakes, healthcare-related applications.
